Stereotaxis to showcase robotic EP automation at HRX 2026

Stereotaxis brings robotic automation to cardiac conference

Stereotaxis will demonstrate its digital surgical robotics portfolio at the Heart Rhythm Society's HRX conference in Atlanta, September 18-20, 2026, as the medical device company advances automation capabilities for minimally invasive cardiac procedures.

The St. Louis-based company will showcase two core technologies: Synchrony, an integrated lab display system that received FDA clearance earlier this year, and SynX, a cloud-based connectivity platform designed for secure remote collaboration. Both systems are already deployed at multiple clinical sites across the United States and Europe, according to details first reported by Globe Newswire.

CEO to address autonomous procedural systems

Stereotaxis Chairman and CEO David Fischel will participate in a main-stage panel titled "Autonomous and Assistive EP Procedural Systems" on September 19 at 11:35 a.m. EDT. The session, moderated by Dr. Peter Weiss and featuring physician panelists Dr. Jim Cheung and Dr. Jennifer Silva, will examine how emerging technologies could improve electrophysiology lab workflows and expand clinical capabilities.

Fischel indicated the company has incorporated initial automation capabilities into its robotic systems and is developing enhanced automation for catheter and interventional device navigation across three specialties: electrophysiology, interventional cardiology, and neurointerventions.

Technical capabilities and compliance

Synchrony consolidates viewing and control of disparate interventional lab systems into customizable layouts that physicians can organize around their specific workflows. The system is bundled with SynX, which provides HIPAA and GDPR-compliant cloud connectivity for recording, monitoring, and remote collaboration during procedures.

The company reports that its technology has been used to treat more than 150,000 patients across the United States, Europe, Asia, and other regions.

Why it matters

The convergence of robotics, AI, and cloud connectivity in interventional cardiology represents a significant shift in how complex cardiac procedures are performed. As healthcare systems face persistent staffing challenges and pressure to expand access to specialized care, remote collaboration tools and procedural automation could help distribute expertise more efficiently. For medical device companies, the integration of cloud platforms with FDA-cleared hardware creates new service models and data opportunities beyond traditional equipment sales—though it also introduces cybersecurity and regulatory complexity that will require ongoing investment.

HRX, pioneered by the Heart Rhythm Society, brings together clinicians, engineers, and entrepreneurs to explore advances in connectivity, artificial intelligence, and automation in cardiovascular medicine.

These details were first reported by Globe Newswire in a company announcement from Stereotaxis.